Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy

Clinical and Experimental Nephrology

Volumn 13, Issue 4, 2009, Pages 402-403

  Gupta, Ankur ^a,b   Khaira, Ambar ^a   Singh, Bakshish ^a   Bhowmik, Dipankar M ^a   Tiwari, Suresh C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; LETTER; MALE; MEMBRANOUS GLOMERULONEPHRITIS; POTASSIUM BLOOD LEVEL; PROTEINURIA;

ADULT; AMIDES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; FUMARATES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68749089676     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0130-5     Document Type: Letter

References (2)

1. ND Fisher NK Hollenberg 2005 Renin inhibition: what are the therapeutic opportunities? J Am Soc Nephrol 16 592 599
2. HH Parving F Persson JB Lewis EJ Lewis NK Hollenberg AVOID Study Investigators 2008 Aliskiren combined with losartan in type 2 diabetes and nephropathy N Engl J Med 358 2433 2446